Mirum Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2020 to Q2 2024.
  • Mirum Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -16.7 %, a 64.5% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Return On Assets for 2023 was -31.5 %, a 24.9% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Return On Assets for 2022 was -42 %, a 24.9% decline from 2021.
  • Mirum Pharmaceuticals, Inc. annual Return On Assets for 2021 was -33.6 %, a 42.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -16.7 +30.5 +64.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -26.5 +11.8 +30.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.5 +10.5 +24.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -36.9 -23.4 -173% Jul 1, 2023 Sep 30, 2023
Q2 2023 -47.2 -28 -146% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.3 -11.8 -44.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42 -8.38 -24.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -13.5 +62.1 +82.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -19.2 +52.6 +73.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.6 +43.1 +61.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.6 +24.5 +42.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -75.6 -21.1 -38.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -71.8 -22.9 -46.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -69.7 -23 -49.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -58.1 Oct 1, 2020 Dec 31, 2020
Q3 2020 -54.5 Jul 1, 2020 Sep 30, 2020
Q2 2020 -49 Apr 1, 2020 Jun 30, 2020
Q1 2020 -46.7 Jan 1, 2020 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.